Performance Evaluation of the NaviAid™ G-Eye System

Colorectal Cancer Clinical Trial

Official title:

Performance Evaluation of the NaviAid™ G-Eye System

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01552200
• Other study ID #: G-Eye 15501
• Status: Completed
• Phase: N/A
• First received: March 6, 2012
• Last updated: April 6, 2014
• Start date: June 2012
• Est. completion date: June 2013

Study information

• Verified date: April 2014
• Source: Smart Medical Systems Ltd.
• Contact: n/a
• Is FDA regulated: No
• Health authority: Israel: Ethics Commission
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to compare the additional diagnostic yield obtained by performing NaviAid™ G-Eye procedure vs. the diagnostic yield obtained by performing standard colonoscopy procedure.

Description:

Colonoscopy is the gold-standard method for CRC screening, as it enables detection and real-time removal of pre-cancerous polyps during the examination. It is well known that lesions are missed during routine colonoscopy.5 major reasons can be detailed for missing polyps during colonoscopy: polyps that are hidden behind folds, polyps that are masked by the colon's topography and natural folds, shallow polyps, unscreened portions of the colon (due to incomplete colonoscopy) and endoscope slippage. The NaviAid™ G-Eye system presents a unique concept that overcomes all 5 items listed above, providing an overall solution to the two endoscopy key challenges of limited detection/treatment yield and limited operation range.

The G-Eye endoscope comprises a standard endoscope onto which a unique balloon is permanently integrated, at its bending section. The NaviAid™ G-Eye may be used for performing controlled withdrawal and endoscope stabilization.

A major attribute of the NaviAid™ G-Eye system controlled withdrawal technique of the endoscope, with the balloon moderately inflated is to expand and stretch the intestinal lumen during endoscope withdrawal.

This is a multicenter, two-arm, randomized, open-label study intended to compare the additional diagnostic yield obtained by performing NaviAid™ G-Eye procedure vs. the diagnostic yield obtained by performing standard colonoscopy procedure.

Subjects will be randomized to one of two groups: Group A, the "Study Group," and Group B, the "Control Group."

Group A: Subjects will undergo a complete standard colonoscopy as the first procedure. Immediately after the standard colonoscopy procedure, a complete NaviAid™ G-Eye procedure will be performed by the same endoscopist.

Group B: Subjects will undergo a complete NaviAid™ G-Eye procedure as the first procedure. Immediately after the NaviAid™ G-Eye procedure, a complete standard colonoscopy will be performed by the same endoscopist.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 126
• Est. completion date: June 2013
• Est. primary completion date: June 2013
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 40 Years and older

Eligibility

Inclusion Criteria:

• The patient is undergoing colonoscopy for screening, for surveillance in follow-up of previous polypectomy or for diagnostic workup;

• The patient is over 40 years old;

• The patient must understand and provide written consent for the procedure.

Exclusion Criteria:

• Subjects with inflammatory bowel disease;

• Subjects with a personal history of polyposis syndrome;

• Subjects with suspected chronic stricture potentially precluding complete colonoscopy;

• Subjects with diverticulitis or toxic megacolon;

• Subjects with a history of radiation therapy to abdomen or pelvis;

• Pregnant or lactating female subjects;

• Subjects who are currently enrolled in another clinical investigation.

• Subjects with routine oral or parenteral use of anticoagulants

• Subjects with recent (within the last 3 mounts) coronary ischemia or CVA (stroke)

• Any patient condition deemed too risky for the study by the investigator

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

• Adenoma
• Colorectal Cancer
• Colorectal Neoplasms
• Polyp

Intervention

Procedure:
• Group A-Standard Colonoscopy, then NaviAid™ G-Eye procedure
Standard Colonoscopy,NaviAid™ G-Eye procedure
• Group B-NaviAid™ G-Eye procedure, then Standard Colonoscopy
G-Eye procedure, Standard Colonoscopy

Locations

Country	Name	City	State
Germany	St. Marienkrankenhaus Frankfurt	Frankfurt
Israel	Hadassah Medical Organization	Jerusalem
Israel	Laniado Hospital	Netanya
Israel	Tel Aviv Sourasky Medical Center	Tel Aviv

Sponsors (1)

Lead Sponsor	Collaborator
Smart Medical Systems Ltd.

Countries where clinical trial is conducted

Germany,  Israel, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	NaviAid™ G-Eye procedure adenoma detection rate compared to the standard colonoscopy procedure adenoma detection rate		Subjects will be followed during the study period (approximatly 3 hours) and follow up will be done within 48-72 hours following the procedure	No